We have previously shown that NF-κB activity in tumor cells increases during ovarian cancer progression using mouse ovarian cancer cells stably expressing an NF-κB-dependent GFP/luciferase reporter, ID8-NGL [10]. The gene discussed is ERBB2; the disease is ovarian carcinoma.